NEW YORK (GenomeWeb News) – OncoDNA today said that it will collaborate with the Integrated BioBank of Luxembourg to provide physicians in Luxembourg with access to next-generation sequencing-based testing for cancer.

Specifically, OncoDNA was chosen by IBBL as a preferred supplier of molecular diagnostics for lung cancer. The Belgium-based firm will provide its OncoDEEP Dx cancer panel, which includes 50 genes and runs on the Ion Torrent PGM, under the alliance.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: omic analysis of permafrost microbes, hookworm genome, and more.

Biologists turn to environmental DNA sampling to determine whether elusive or invasive species are shedding DNA in a given area.

Rob Knight writes at Scientific American that microbiome studies are about to break out of the laboratory.

Harold Varmus, the director of the National Cancer Institute, has announced that he is stepping down after nearly five years.